Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial.
C Louwrens BraalAnne KleijburgAgnes JagerStijn L W KoolenRon H J MathijssenIsaac Corro RamosPim WetzelaerCarin A Uyl-de GrootPublished in: Clinical drug investigation (2022)
TDM-guided dose optimization of tamoxifen is estimated to save costs and increase QALYs for early breast cancer patients.